At the committee meeting, she said that Trump has already axed over 800 grants and billions of dollars in research funding, ...

According to the Elsevier 2024 Gender Equality in Research & Innovation Report, women researchers are well-represented across ...

Novartis has reached an agreement to buy Regulus Therapeutics and its experimental therapy for autosomal dominant polycystic ...

Abeona Therapeutics' Zevaskyn, a cell therapy based on engineered keratinocytes harvested from patients, has been approved in ...

Novo Nordisk has sought strength in numbers in the battle for telehealth obesity drug sales in the US, enlisting the aid of ...

AZ has already thrown down a marker for its tougher stance on Europe, with an earlier decision to abandon a $560 million ...

In its update, GSK reported a 17% rise in specialty medicines across its HIV, cancer, and respiratory business to £2.93 ...

Grambley discusses how AI can be leveraged to create highly personalised patient engagement strategies, tailored to ...

Merck KGaA has reached an agreement with SpringWorks on a $47-per-share takeover deal that values the US biotech at $3.9 ...

Abstract 1679, under the session ‘Drug Combination Strategies for Cancer Treatment’, showed that APG-2449, a novel focal ...

The platform's library of specialised life sciences agents creates an adaptable framework that breaks down silos between data ...

Pharming's Joenja has become the first disease-modifying drug that can be used by the NHS to treat activated phosphoinositide ...